Press releases

28
Jul 2025
20:30 E.S.T.

Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025

Read more
26
Jun 2025
20:30 E.S.T.

Cellectis Reports Results from Shareholders Meeting Held on June 26, 2025

Read more
21
May 2025
20:30 E.S.T.

Cellectis’ Annual Shareholders General Meeting to be Held on June 26, 2025

Read more
12
May 2025
20:30 E.S.T.

Cellectis Reports Financial Results for the First Quarter 2025

Read more
12
May 2025
09:30 E.S.T.

Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress

Read more
6
May 2025
20:30 E.S.T.

Cellectis to Report First Quarter Financial Results on May 12, 2025

Read more
28
Apr 2025
20:30 E.S.T.

Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting

Read more
13
Mar 2025
22:15 E.S.T.

Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update

Read more
7
Mar 2025
09:36 E.S.T.

Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025

Read more
24
Feb 2025
06:30 E.S.T.

Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US